Matt D'Auria

Sales & Marketing

Matt D’Auria is a talent-centric leader who has been building and leading medical communications teams for over 20 years.

Digital

Dr Alan Roth, CEO of Oxford Drug Design, discusses the use of AI to accelerate discovery of new treatments.

Sales & Marketing

The findings from the Medidata-commissioned survey confirm that AI implementation in clinical trials has moved firmly beyond theoretical discussion.